Search & Analyze

Manipal Health Enterprises Ltd.

HealthcareHospital & Healthcare Services

www.manipalhospitals.com BSE: 544847NSE: MANIPALHOS

₹714.45BSE2.09%

16 Sep, 4:01 PM

₹714.45

₹93.98K Cr

105.32

5.15

12.95%

₹719.15

₹690.50

₹813.70

₹626.00

Customise metrics bar

Price Performance

Peer Comparison

Name
APOLLO HOSP. APOLLOHOSP	8,712.95	59.96	1,25,278.85	0.23	610.40	38.41%	7,043.50	20.56%	21.73
MAXHEALTH MAXHEALTH	1,032.60	68.98	1,00,504.02	0.19	322.96	4.87%	2,366.17	16.70%	14.97
Manipal Health Enterprises Ltd. MANIPALHOS	714.45	105.32	93,977.12	0.00	243.43	-4.18%	3,090.63	38.12%	13.93
FORTIS FORTIS	868.50	62.57	65,568.12	0.12	272.80	2.26%	2,545.03	17.46%	14.07
ASTERDM ASTERDM	740.00	202.67	64,503.76	0.40	29.28	-68.70%	1,310.68	21.60%	16.22
NH NH	1,855.25	46.37	37,914.04	0.24	207.27	5.37%	2,683.63	78.05%	16.20
MEDANTA MEDANTA	1,406.40	67.92	37,814.13	0.04	157.25	-1.09%	1,304.05	26.50%	19.38
KIMS KIMS	766.10	157.77	32,176.70	0.00	37.40	-56.00%	1,179.50	35.33%	11.51

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2025	Jun 2026
	2,237.63	3,090.63
Expenses	1,651.15	2,354.02
	586.48	736.61
	26.21%	23.83%
	29.95	59.09
Interest	131.61	293.27
	140.63	187.25
	344.19	315.18
	26.19%	22.76%
	250.37	231.65
	2.17	1.96

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME:
Operating Income	3,975.22	4,805.93	6,171.63	8,242.25	10,335.75
Operating Income (Net)	3,975.22	4,805.93	6,171.63	8,242.25	10,335.75
EXPENDITURE :
Increase/Decrease in Stock	-29.83	14.34
Cost of Medicines and Consumables	1,021.86	974.29	1,251.21	1,680.04	2,116.16
Power & Fuel Cost	68.62	82.12	96.50	117.82	141.89
Employee Cost	552.28	657.59	857.04	1,219.41	1,490.04
Hospital Operation Expenses	1,013.39	1,272.57	1,623.03	2,156.23	2,847.83
Selling, Administration and Other Expenses	309.82	437.69	577.72	798.29	936.27
Miscellaneous Expenses	139.39	123.05	86.76	180.79	192.40
	3,075.53	3,561.65	4,492.24	6,152.57	7,724.58
Operating Profit (Excl OI)	899.69	1,244.28	1,679.39	2,089.68	2,611.17
	109.15	88.13	97.22	157.39	184.77
	1,008.84	1,332.41	1,776.60	2,247.07	2,795.94
Interest	325.59	329.45	454.93	511.87	864.29
PBDT	683.25	1,002.96	1,321.68	1,735.20	1,931.65
	256.00	315.27	397.02	506.84	679.55
Profit Before Taxation & Exceptional Items	427.25	687.69	924.66	1,228.36	1,252.10
Exceptional Income / Expenses	209.91	-102.12	-179.63	13.95	-74.07
	637.16	585.57	745.04	1,242.31	1,178.03
Provision for Tax	90.46	156.54	211.83	160.64	261.51
	546.70	429.03	533.20	1,081.67	916.52
Extra items	-4.98	0.00	0.00	0.00	0.00
Minority Interest	0.16	-1.71	61.12	-16.31	-24.20
Consolidated Net Profit	541.88	427.32	594.32	1,065.36	892.32
Profit Balance B/F	-352.59	189.29	654.73	1,283.22	2,330.83
Appropriations	189.29	616.61	1,249.05	2,348.58	3,223.15
	71.65	56.50	78.58	138.25	7.56
Adjusted EPS	4.78	3.77	5.24	46.08	7.56

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	75.63	75.63	75.63	77.06	235.95
Share Warrants & Outstandings	17.98	22.56	1.93	40.76	73.73
Total Reserves	2,714.46	3,143.93	3,937.97	5,729.52	8,116.41
Reserve excluding Revaluation Reserve	2,714.46	3,143.93	3,937.97	5,729.52	8,116.41
Revaluation reserve	0.00	0.00	0.00	0.00	0.00
	2,808.07	3,242.12	4,015.54	5,847.34	8,426.09
Minority Interest	99.77	123.61	71.98	152.83	372.67
Secured Loans	1,604.31	1,948.35	3,700.14	4,469.98	9,948.81
Deferred Tax Assets / Liabilities	171.70	157.75	149.59	2.14	152.38
Other Long Term Liabilities	898.29	1,062.03	1,133.67	1,583.83	2,409.17
Long Term Provisions	24.92	14.87	29.83	39.55	63.17
Total Non-Current Liabilities	2,699.22	3,183.00	5,013.23	6,095.50	12,573.53
Trade Payables	667.52	766.56	1,130.52	1,126.59	1,464.54
Other Current Liabilities	618.40	175.39	450.32	596.07	1,826.36
Short Term Borrowings	369.53	201.34
Short Term Provisions	83.65	71.19	75.90	72.14	71.47
Total Current Liabilities	1,739.10	1,214.48	1,656.74	1,794.80	3,362.37
Total Liabilities	7,346.16	7,763.21	10,757.48	13,890.47	24,734.66
Gross Block	6,342.69	6,839.09	11,486.30	13,703.98	23,536.82
Less: Accumulated Depreciation	1,858.32	2,096.65	3,327.87	3,877.81	4,783.95
Net Block	4,484.37	4,742.44	8,158.43	9,826.17	18,752.87
Capital Work in Progress	207.93	39.75	41.59	614.03	795.30
Non Current Investments	179.12	128.56	116.17	144.91	282.84
Long Term Investment	179.12	128.56	116.17	144.91	282.84
Long Term Loans & Advances	203.72	219.33	325.02	357.68	723.17
Other Non Current Assets	30.60	44.75	58.33	93.05	71.50
Total Non-Current Assets	5,986.40	6,168.46	8,699.53	11,035.85	20,625.66
Currents Investments	687.21	951.10	1,004.92	1,630.76	2,392.35
Inventories	77.40	63.06	103.18	131.93	169.85
Sundry Debtors	297.81	309.37	458.88	637.30	929.76
Cash and Bank	161.64	162.35	379.79	330.29	323.21
Other Current Assets	54.99	43.90	50.28	63.87	116.21
Short Term Loans and Advances	74.21	58.47	54.40	53.97	171.12
Total Current Assets	1,353.26	1,588.25	2,051.45	2,848.12	4,102.50
Net Current Assets (Including Current Investments)	-385.84	373.77	394.70	1,053.32	740.12
Total Assets	7,346.16	7,763.21	10,757.48	13,890.47	24,734.66
Contingent Liabilities	818.31	851.62	268.00	233.61	146.31
Total Debt	1,973.84	2,149.69	3,943.98	4,766.83	10,287.54
	368.91	425.70	530.69	753.50	70.80
Adjusted Book Value	24.59	28.38	35.38	251.17	70.80

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	637.16	585.57	745.04	1,242.31	1,178.03
Adjustment	456.22	711.48	898.67	993.00	1,487.39
Changes In working Capital	-195.23	50.03	36.30	-375.63	-164.95
Cash Flow after changes in Working Capital	898.15	1,347.08	1,680.00	1,859.68	2,500.47
Cash Flow from Operating Activities	804.53	1,149.31	1,388.65	1,569.83	2,078.40
Cash Flow from Investing Activities	-1,711.13	-994.09	-870.50	-2,658.34	-7,036.74
Cash Flow from Financing Activitie	940.90	-143.55	-250.21	904.08	4,954.44
Net Cash Inflow / Outflow	34.30	11.67	267.94	-184.43	-3.90
Opening Cash & Cash Equivalents	22.23	56.53	68.20	360.88	291.28
Cash & Cash Equivalent on Amalgamation / Take over / Merger			24.74	114.83	11.97
Closing Cash & Cash Equivalent	56.53	68.20	360.88	291.28	299.35

Ratios

Valuation

105.32

5.15

37.18

9.09

6.78

138.69

Profitability

12.95

13.93

4.75

25.26

8.87

Leverage & Liquidity

1.23

1.22

2.36

Returns

0.00

0.54

Shareholding Pattern

Numbers in percentages

Particulars	Mar '24	Mar '25	Aug '26
			72.08
			9.11
	100.00	100.00	18.81
	100.00	100.00	27.92
No. of Shareholders	12	13	3,38,074

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-09-09	AGM
2026-08-14	Board Meeting	Quarterly Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcareHospital & Healthcare Services

Manipal Health Enterprises Ltd. operates in the Healthcare sector under the Hospital & Healthcare Services industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

13 members across the board and senior leadership

Hebri Sudarshan Ballal

Chairman

—

Dilip Jose Puthiyidathu

Managing Director & Chief Executive Officer

₹6.62 Cr

Mar '26

Ranjan Ramdas Pai

Nominee Director of MGHS Group

—

Puneet Bhatia

Non Executive Director

—

Vinesh Kumar Jairath

Non Executive Independent Director

₹4.00 L

Mar '26

Subramaniam Somasundaram

Non Executive Independent Director

₹3.50 L

Mar '26

Ravi Mahinder Lambah

Non Executive Director

—

Revathy Ashok

Non Executive Independent Director

₹2.00 L

Mar '26

Ved Prakash Kalanoria

Non Executive Director

—

Sathish Kolar Ramamoorthy

Company Secretary & Compliance Officer

—

Varini Sharma

Non Executive Director

—

Ravi Lambah

Nominee Director of Kangto Investments Pte. Ltd. and Kabru Investments Pte. Ltd.

—

Ved Kalanoria

Nominee Director of Kangto Investments Pte. Ltd. and Kabru Investments Pte. Ltd.

—

MANIPALHOS Latest News

News

6 of 6 articles

EQUITY18 Aug 2026 · 10:24

Manipal Health gains on signing BTA to acquire Kinder Women’s Hospital in Bengaluru

The acquisition is allied to the current business and would result in growth opportunities in line with the strategic directions of the company

COMPANY18 Aug 2026 · 10:10

Manipal Health signs BTA to acquire Kinder Women’s Hospital and Fertility Centre in Bengaluru

The acquisition is allied to the current business and would result in growth opportunities in line with the strategic directions of the company

EQUITY5 Aug 2026 · 10:26

Manipal Health Enterprises lists with 11% premium on the BSE

The scrip is currently trading at Rs. 653.70, up by 63.70 points or 10.80% from its issue price

IPO28 Jul 2026 · 13:06

Manipal Health Enterprises coming with IPO to raise Rs 9,705.54 crore

The issue will open for subscription on July 29, 2026 and will close on July 31, 2026

IPO7 Jul 2026 · 12:38

Manipal Health Enterprises gets SEBI’s nod to raise funds via IPO

Apart from the fresh issue, there will be an offer-for-sale of 43,227,668 equity shares by promoters

IPO27 Mar 2026 · 17:26

Manipal Health Enterprises files preliminary papers with SEBI for IPO

Proceeds from its fresh issuance worth Rs 5,378 crore will be utilised for loan payments availed by the company's arm, Manipal Hospitals

MANIPALHOS

₹714.45

+2.09%